Quantcast
Specialized Immune Cells Could Stop Cancer Spread

Specialized Immune Cells Could Stop Cancer Spread

Walter and Eliza Hall Institute of Medical Research Melbourne researchers have revealed the critical importance of highly specialized immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. These...

Latest cancers Stories

cancer classification system
2014-08-10 05:02:57

Rayshell Clapper for redOrbit.com - Your Universe Online Researchers released some pretty incredible findings last week about cancer. In a multiple institute study including researchers and authors from the University of California at Santa Cruz (UCSC), the Buck Institute for Research on Aging, the University of California at San Francisco (UCSF), the University of North Carolina, Chapel Hill (UNC), and the Broad Institute of Harvard and MIT looked closely at how cancers are classified....

2014-08-08 10:45:03

Queen Mary, University of London New research from Queen Mary University of London (QMUL) reveals taking aspirin can significantly reduce the risk of developing – and dying from – the major cancers of the digestive tract, i.e. bowel, stomach and oesophageal cancer. For the first time, scientists have reviewed all the available evidence from many studies and clinical trials assessing both the benefits and harms of preventive use of aspirin. Conclusions of the study, funded by Cancer...

2014-07-30 23:15:58

Genomics R&D firm, Ryogen LLC, received two U.S. Patents – its 31st and 32nd – that are directed to polynucleotide sequences that play critical roles in various cancers. Suffern, N.Y. (PRWEB) July 30, 2014 Ryogen LLC, an R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded two new patents this month, bringing the total number of its issued U.S. Patents to 32. U.S. Patent No. 8,765,928 entitled “Identification of isolated genomic...

2014-07-28 23:01:59

Individuals diagnosed with a covered Cancer on or prior to October 12, 2012 are included in the October 12, 2014 deadline. Port Washington, NY (PRWEB) July 28, 2014 Parker Waichman LLP, a personal injury law firm that has spent many years fighting to ensure that the heroes of 9/11 are never forgotten, comments that the September 11th Victims Compensation Fund (VCF) has announced an important deadline. According to a VCF message dated July 3, 2014, individuals who were diagnosed with a...

2014-07-26 23:01:54

The Firm is investigating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to uterine morcellation. New York, New York (PRWEB) July 26, 2014 As morcellator lawsuits (http://www.gynecaremorcellatorlawsuit.com/) continue to be filed in U.S. courts, Bernstein Liebhard LLP notes that more doctors and patients are calling on federal health regulators to ban uterine morcellation. According to a report from The Chicago...

2014-07-14 12:55:18

The Lancet Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe, according to the largest population-based study of survival in European adults to date, published in The Lancet Oncology. "The good news is that 5-year survival for most cancers of the blood has increased over the past 11 years, most likely reflecting the approval of new targeted drugs in...

2014-07-04 23:02:25

Deaths from mesothelioma and other rare cancers now account for more than half of the cancer deaths in the UK, even though they make up less than half of those diagnosed. Raleigh, NC (PRWEB) July 04, 2014 A new report from a British organization that represents rare cancer charities says cancers like mesothelioma now account for 54% of cancer deaths in the UK – a new high for the country. Surviving Mesothelioma has just posted details of the new report on their website. Click here to...

2014-06-27 23:02:29

The Firm is investigating morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to the use of power morcellators in gynecological surgeries. New York, New York (PRWEB) June 27, 2014 As it continues its investigation of hysterectomy cancer lawsuits (http://www.gynecaremorcellatorlawsuit.com/) on behalf of women who allegedly experienced the spread of uterine cancers due to power morcellators, Bernstein Liebhard LLP notes that...

2014-06-25 11:27:24

University of Minnesota Gene partnership may be fueling cancer spread in as much as 20 percent of cancers A key cancer-causing gene, responsible for up to 20 percent of cancers, may have a weak spot in its armor, according to new research from the Masonic Cancer Center, University of Minnesota. The partnership of MYC, a gene long linked to cancer, and a non-coding RNA, PVT1, could be the key to understanding how MYC fuels cancer cells. The research is published in the latest issue...

2014-06-25 08:31:35

Oral Cancer Detection Test For Primary Care Physicians GARDEN CITY, N.Y., June 25, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium Medical Devices LLC, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.